Meet ICON at CPHI
28-30 October, Frankfurt, Germany
Reduce drug development timelines and improve clinical outcomes with ICON's Accelerated Pharmaceutical solutions
ICON’s provides a seamless, end-to-end approach to formulation development and optimisation for small molecules and biologics. Our comprehensive accelerated pharmaceutical solutions cover everything from formulation screening and optimisation to analytical method development validation, and custom packaging, labelling, and distribution—including specialised support for oncology drugs and carbon-14 labelled products.
With GMP-compliant manufacturing sites equipped with on-site GMP Quality Control (QC) laboratories, we streamline formulation development and stability/compatibility studies, enabling faster early clinical manufacturing for early phase studies in both healthy volunteers and patients across Europe and the U.S.
Meet our experts at CPHI (Booth #6 IF95) to learn how our full suite of solutions can support your clinical development programme.
Our experts will also be presenting at the following sessions within the clinical innovation track:
28th October 11.35 – 12.20
Panel session: From Collaboration to Commitment: Strengthening CRO-End User Relationships
Arjen Akerman
Senior Director, Accelerated Pharmaceutical Solutions
28th October 2.15 – 2.45
Enabling dosing flexibility in early phase trials: An integrated CMC and manufacturing strategy
Suzanne Jansen
Head of QC, Accelerated Pharmaceutical Solutions
Meet our experts
Submit our short form to request a meeting with one of our experts at CPHI